|
|
 Previous Article | Table of Contents | Next Article 
SHP-1 Phosphatase C-Terminus Interacts With Novel Substrates
p32/p30 During Erythropoietin and Interleukin-3 Mitogenic Responses
Wentian Yang,
Mina Tabrizi,
Karim Berrada, and
Taolin Yi
From the Department of Cancer Biology, The Lerner Research Institute
of the Cleveland Clinic Foundation, Cleveland, OH.
SHP-1 protein tyrosine phosphatase is a critical negative regulator
of mitogenic signaling, as demonstrated by the heightened growth
responses to hematopoietic growth factors in hematopoietic cells of
motheaten mice, which lack functional SHP-1 expression due to mutations
in the SHP-1 gene. The mitogenic signaling molecules dephosphorylated
by SHP-1 have not been fully identified. We detected two proteins
(p32/p30) that are hyperphosphorylated in a DA3/erythropoietin receptor
(EpoR) cell line that expresses a mutant containing the SHP-1
C-terminus that suppresses the function of the endogenous phosphatase
and induces hyperproliferative responses to interleukin-3 (IL-3) and
Epo. Hyperphosphorylated p32/p30 are also detected in motheaten
hematopoietic cells, demonstrating an association of p32/p30
hyperphosphorylation with SHP-1-deficiency and growth factor-hyperresponsiveness. The hyperphosphorylated p32/30 associate with SHP-1 via its C-terminus, because they coimmunoprecipitate with
the phosphatase and the C-terminal mutant and they bind in vitro to a
synthetic peptide of the mutant but not the GST fusion proteins of
SHP-1 SH2 domains. Induction of p32/p30 phosphorylation by IL-3 or Epo
occurs mainly at 2 to 18 hours poststimulation in the DA3/EpoR cell
line, indicating p32/p30 as novel signaling molecules during cell cycle
progression. These data demonstrate a function for the SHP-1 C-terminus
in recruiting potential substrates p32/p30 and suggest that SHP-1 may
regulates mitogenic signaling by dephosphorylating p32/p30.
Blood, Vol. 91 No. 10 (May 15), 1998:
pp. 3746-3755
© 1998 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. Frank, C. Burkhardt, D. Imhof, J. Ringel, O. Zschornig, K. Wieligmann, M. Zacharias, and F.-D. Bohmer
Effective Dephosphorylation of Src Substrates by SHP-1
J. Biol. Chem.,
March 19, 2004;
279(12):
11375 - 11383.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Zhang, E. Jimi, and A. L. M. Bothwell
Receptor Activator of NF-{kappa}B Ligand Stimulates Recruitment of SHP-1 to the Complex Containing TNFR-Associated Factor 6 That Regulates Osteoclastogenesis
J. Immunol.,
October 1, 2003;
171(7):
3620 - 3626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Pathak, D. Dhawan, D. J. Lindner, E. C. Borden, C. Farver, and T. Yi
Pentamidine Is an Inhibitor of PRL Phosphatases with Anticancer Activity
Mol. Cancer Ther.,
December 1, 2002;
1(14):
1255 - 1264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Oka, M. Ouchida, M. Koyama, Y. Ogama, S. Takada, Y. Nakatani, T. Tanaka, T. Yoshino, K. Hayashi, N. Ohara, et al.
Gene Silencing of the Tyrosine Phosphatase SHP1 Gene by Aberrant Methylation in Leukemias/Lymphomas
Cancer Res.,
November 15, 2002;
62(22):
6390 - 6394.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Oka, T. Yoshino, K. Hayashi, N. Ohara, T. Nakanishi, Y. Yamaai, A. Hiraki, C. A. Sogawa, E. Kondo, N. Teramoto, et al.
Reduction of Hematopoietic Cell-Specific Tyrosine Phosphatase SHP-1 Gene Expression in Natural Killer Cell Lymphoma and Various Types of Lymphomas/Leukemias : Combination Analysis with cDNA Expression Array and Tissue Microarray
Am. J. Pathol.,
October 1, 2001;
159(4):
1495 - 1505.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. K. Pathak and T. Yi
Sodium Stibogluconate Is a Potent Inhibitor of Protein Tyrosine Phosphatases and Augments Cytokine Responses in Hemopoietic Cell Lines
J. Immunol.,
September 15, 2001;
167(6):
3391 - 3397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Wang, Y. Miyakawa, N. Fox, and K. Kaushansky
Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1
Blood,
September 15, 2000;
96(6):
2093 - 2099.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Fournier, L. Chalus, I. Durand, E. Garcia, J.-J. Pin, T. Churakova, S. Patel, C. Zlot, D. Gorman, S. Zurawski, et al.
FDF03, a Novel Inhibitory Receptor of the Immunoglobulin Superfamily, Is Expressed by Human Dendritic and Myeloid Cells
J. Immunol.,
August 1, 2000;
165(3):
1197 - 1209.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-J. Jin, C.-L. Yu, and S. J. Burakoff
Human 70-kDa SHP-1L Differs from 68-kDa SHP-1 in Its C-terminal Structure and Catalytic Activity
J. Biol. Chem.,
October 1, 1999;
274(40):
28301 - 28307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-J. Jin, C.-L. Yu, and S. J. Burakoff
Human 70-kDa SHP-1L Differs from 68-kDa SHP-1 in Its C-terminal Structure and Catalytic Activity
J. Biol. Chem.,
October 1, 1999;
274(40):
99999 - 99999.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. Umeda, W. G. Beamer, K. Takagi, M. Naito, S.-I. Hayashi, H. Yonemitsu, T. Yi, and L. D. Shultz
Deficiency of SHP-1 Protein-Tyrosine Phosphatase Activity Results in Heightened Osteoclast Function and Decreased Bone Density
Am. J. Pathol.,
July 1, 1999;
155(1):
223 - 233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Dong, K. A. Siminovitch, L. Fialkow, T. Fukushima, and G. P. Downey
Negative Regulation of Myeloid Cell Proliferation and Function by the SH2 Domain-Containing Tyrosine Phosphatase-1
J. Immunol.,
March 15, 1999;
162(6):
3220 - 3230.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-M. Pasquet, L. Quek, S. Pasquet, A. Poole, J. R. Matthews, C. Lowell, and S. P. Watson
Evidence of a Role for SHP-1 in Platelet Activation by the Collagen Receptor Glycoprotein VI
J. Biol. Chem.,
September 8, 2000;
275(37):
28526 - 28531.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
